Background. Peripheral blood count is the first investigation to be done in every @entity1 before surgery. As strong relationship exists between @entity5 and immune response of the body, clinical stage at presentation and altered hematological parameters can influence the progression of @entity5 and vice versa. Settings and Design. It is a case control study of total 50 cases (35 cases of @entity189 breast and 15 cases of @entity1558 ). Methods. A case control study was carried out; 35 cases of @entity0 @entity1 were taken prior to surgery and chemotherapy with 15 cases of @entity1558 as control. Clinical staging according to the @entity5 ( @entity5 ) was done and was correlated with complete blood count (CBC). Results. All the @entity5 @entity1 were females with overall mean age of 47.96    13.84 years. Amongst all altered blood parameters, correlation of absolute lymphocytic count (p value 0.001) with @entity5 staging was found significant. Particularly, decrease in absolute leucocytic count was observed with increase in stage of @entity0 . Conclusions. The stage-specific mean values of absolute lymphocytic counts of preoperative @entity0 @entity1 can be used as an economical tool to know the evolution of disease.

Preoperative Peripheral Blood Count in XXXX : Predictor of Prognosis or a Routine Test.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity0 :: ('MESH:D001943', 'Disease') :: ['breast carcinoma', 'breast cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor, node, and metastasis classification', 'TNMc', 'cancer'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinoma'] @entity1558 :: ('MESH:D001941', 'Disease') :: ['benign breast disease']
@entity0 :: (MESH:D001943,Disease) :: ['Breast Carcinoma']
